Director of National Intelligence Tulsi Gabbard has ordered a sweeping review of more than 120 foreign laboratories that received U.S. funding — including more than 40 sites in Ukraine. This is not a movie plot about a secret “new virus.” It is an overdue inventory and oversight check that should have happened years ago. The questions we need answered are simple: What did we fund, who ran the work, and is any dangerous material at risk in a war zone?
What the DNI Review Actually Is
Let’s be clear. The Office of the Director of National Intelligence is doing an inventory. Director of National Intelligence Tulsi Gabbard told reporters the effort is to “identify where these labs are, what pathogens they contain and what ‘research’ is being conducted.” That lines up with public reporting: this is a mapping-and-assessment effort, not a criminal indictment or a discovery of a mysterious new pathogen. Media outlets and fact-checkers note there is no verified report of a “new virus” tied to the review.
Why Conservatives Should Care — And Not Be Suckered
Conservatives should welcome oversight. We rightly worry about taxpayer money, national security, and experiments that could cross dangerous lines like gain-of-function work. The Trump administration’s executive steps to limit federal support for certain risky research are part of the reason this review exists. But let’s also be wary of being spoon-fed conspiracy. Past claims that U.S. programs secretly ran offensive bioweapons labs in Ukraine have been debunked by multiple fact-checkers. That doesn’t mean the work funded was trivial — it means we must stick to the facts and demand audits, not headlines.
Ukraine, War Zones, and Real Risks
Here’s where the urgency is real: many partner labs supported by U.S. programs were in countries now facing conflict. Ukraine has dozens of sites that received upgrades, training, and diagnostic support under long-running programs like the Defense Threat Reduction Agency’s Biological Threat Reduction Program. When a country is at war, chain of custody for dangerous samples and the physical security of facilities become real problems. If we care about American safety, we should push for fast, transparent answers about samples, records, and who has access now.
Demand Transparency — Not Theatrics
It’s commonsense: demand the ODNI and Defense Department publish what they can, then strip-cover what must remain classified for security. Congress should hold hearings, ask tough questions, and insist on a public accounting of U.S. funding streams to foreign labs. And newsrooms should stop running with sensational clickbait about “new viruses” until real evidence shows up. Oversight and honesty beat drama every time — especially when public health and national security are on the line. If the review finds problems, fix them quickly. If it doesn’t, we should still learn the lessons and stop letting sloppy funding and murky reporting become national-security liabilities.

